GlassScriptPhysician profile
Mark T Dickinson
NPI 1215914239
$7,728.93
in general payments reported to CMS, 2019-2025
31 companies · $637 in 2025
The $637 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $164 · 2021: $1,519 · 2022: $1,450 · 2023: $1,024 · 2024: $2,601 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775 · Education: $1,523 · Travel and Lodging: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,774.55 |
| Education | $1,523.44 |
| Travel and Lodging | $963.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,463.52 | 2023-2024 | Da Vinci Surgical System |
| Axonics, INC. | $1,350.77 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $724.92 | 2021-2025 | Axonics, Lithovue, Lithoclast |
| Medtronic, INC. | $644.99 | 2021-2023 | Interstim |
| Medtronic USA, INC. | $428.03 | 2019-2020 | |
| Myovant Sciences INC. | $311.46 | 2021-2022 | |
| Calyxo, INC. | $287.92 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $208.19 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $148.16 | 2021-2025 | Prolaris |
| Srs Medical Systems, INC. | $140.66 | 2021 | |
| Teleflex LLC | $130.94 | 2021-2023 | Urolift |
| Antares Pharma, INC. | $119.76 | 2021-2022 | |
| Angiodynamics, INC. | $110.21 | 2022 | |
| Astellas Pharma US INC | $94.91 | 2019-2022 | |
| Allergan, INC. | $72.63 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $63.61 | 2021-2022 | |
| Mission Pharmacal Company | $61.52 | 2022 | |
| Abbvie INC. | $55.22 | 2022-2023 | Botox |
| Merck Sharp & Dohme LLC | $47.48 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $41.22 | 2021-2022 | |
| Janssen Biotech, INC. | $40.80 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $32.44 | 2022 | |
| Clarus Therapeutics INC. | $27.92 | 2021 | |
| Endo Pharmaceuticals INC. | $20.27 | 2021 | |
| Coloplast Corp | $19.68 | 2022 | |
| Trevena, INC. | $17.30 | 2021 | |
| Accord Healthcare, INC. | $16.00 | 2022 | |
| Laborie Medical Technologies Corp. | $15.88 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.87 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $13.09 | 2022 | |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dickinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.